Search results
AI clinical insights platform Regard receives $61m in Series B financing
Hospital Management· 14 hours agoIn 2021, Regard received $5m in seed investment, followed by $15.3m in a Series A financing round...
Pfizer moves forward with once-daily weight loss pill
Clinical Trials Arena· 2 days agoNovo Nordisk currently dominates the space with its GLP-1 agonist drug Wegovy (semaglutide) which...
Vivani to start in-human trial for GLP-1 implant for treating obesity
Clinical Trials Arena· 18 hours agoGlobalData is the parent company of Clinical Trials Arena. Weight loss therapies including Novo...
Vivani to start in-human trial for GLP-1 implant for treating obesity
Medical Device Network· 18 hours agoGlobalData estimates that GLP-1 receptor agonist sales for T2D and obesity markets will reach more...
Does anyone believe in the Aggies?
Deseret News· 3 days agoThe Utah State Aggies were picked to finish seventh in the Mountain West Conference in 2024, another middle-of-the-road placement. | Eli Lucero/The...
Pfizer moves forward with once-daily weight loss pill after scrapping earlier version - ETPharma
The Economic Times· 2 days agoThe new drug is part of the second-generation of weight-loss pills, under development by companies...
US Senator Sanders optimistic Novo Nordisk can be pressured to cut Wegovy, Ozempic prices - ET...
The Economic Times· 2 days agoWashington: Senator Bernie Sanders on Wednesday expressed confidence that Novo Nordisk can be...
Pfizer thinks it found its obesity pill
BioPharma Dive· 2 days agoFar behind companies like Novo and Eli Lilly, Pfizer hopes the version of the drug, danuglipron, that it’s chosen to advance can break into the...
Gathering will mark 45 years since the largest radioactive release in U.S. history hit New Mexico
Source New Mexico· 21 hours agoIt’s been 45 years since the largest radioactive release in U.S. history occurred at Church Rock New...
Most patients stop using Wegovy, Ozempic for weight loss within two years, analysis finds - ET...
The Economic Times· 3 days agoLondon: Only one in four U.S. patients prescribed Novo Nordisk's Wegovy or Ozempic for weight loss...
